We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Acelrx Pharmaceuticals Inc
65 own
70 watching
Current Price
$1.11
$0.16
(16.84%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
9.15M
52-Week High
7.6
52-Week Low
0.55
Average Volume
0.48M
Dividend Yield
--
P/E Ratio
--
Market Capitalization9.15M52-Week High7.652-Week Low0.55Average Volume0.48MDividend Yield--P/E Ratio--What does the Acelrx Pharmaceuticals Inc do?
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet, which is in Phase III clinical trial for the treatment of moderate-to-severe acute pain. The company's late-stage investigational product candidate is Zalviso, a pre-programmed and patient-controlled analgesia device that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. Zalviso is approved in the European Union, Switzerland, Liechtenstein, Iceland, Norway and Australia, or the Territory; and is under development stage in the United States. The company was formerly known as SuRx Pharmaceuticals, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood City, California.
Read More
How much money does Acelrx Pharmaceuticals Inc make?
News & Events about Acelrx Pharmaceuticals Inc.
PR Newswire
1month ago
AcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA to Alora Pharmaceuticals AcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA to Alora Pharmaceuticals PR Newswire HAYWARD, Calif., April 5, 2023 In connection with closing, AcelRx received approximately $2.7 million from...
Zolmax
4 months ago
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX Get Rating) was the target of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 878,500 shares, an increase of 12.5% from the November 30th total of 780,600 shares. Currently, 12.0% of ...
Ticker Report
4 months ago
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX Get Rating) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 878,500 shares, an increase of 12.5% from the November 30th total of 780,600 shares. Approximately 12.0% of the...
PR Newswire
5 months ago
AcelRx Announces $7.5 Million Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock AcelRx Announces $7.5 Million Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock PR Newswire HAYWARD, Calif., Dec. 27, 2022 HAYWARD, Calif., Dec. 27, 2022...
PR Newswire
7 months ago
AcelRx Pharmaceuticals Announces Presentation of a Large Cohort of Complex Plastic Surgery Procedures Performed with DSUVIA at Plastic Surgery The Meeting 2022 AcelRx Pharmaceuticals Announces Presentation of a Large Cohort of Complex Plastic Surgery Procedures Performed with DSUVIA at Plastic...
Frequently Asked Questions
Frequently Asked Questions
What is Acelrx Pharmaceuticals Inc share price today?
Can Indians buy Acelrx Pharmaceuticals Inc shares?
How can I buy Acelrx Pharmaceuticals Inc shares from India?
Can Fractional shares of Acelrx Pharmaceuticals Inc be purchased?
What are the documents required to start investing in Acelrx Pharmaceuticals Inc stocks?
What is today’s traded volume of Acelrx Pharmaceuticals Inc?
What is today’s market capitalisation of Acelrx Pharmaceuticals Inc?
What is the 52-Week High and Low Range of Acelrx Pharmaceuticals Inc?
What percentage is Acelrx Pharmaceuticals Inc down from its 52-Week High?
What percentage is Acelrx Pharmaceuticals Inc up from its 52-Week Low?
Current Price
$1.11
$0.16
(16.84%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.